[Diagnostic journey of type 1 Gaucher Disease patients: A survey including internists and hematologists].

Parcours diagnostique des patients atteints de maladie de Gaucher de type 1 : enquête auprès de médecins internistes et hématologues.

Journal

La Revue de medecine interne
ISSN: 1768-3122
Titre abrégé: Rev Med Interne
Pays: France
ID NLM: 8101383

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 19 09 2018
revised: 22 06 2019
accepted: 15 07 2019
pubmed: 11 9 2019
medline: 27 6 2020
entrez: 11 9 2019
Statut: ppublish

Résumé

Gaucher disease (GD) is a rare genetic lysosomal storage disorder caused by a beta-glucocerebrosidase deficiency and responsible for a lysosomal storage disorder. GD is characterized by haematological, visceral and bone involvements. The aim of this study was to describe the diagnostic journey of type 1 GD patients as well as the role of the internist. A retrospective multicentric study involving type 1 GD patients has been conducted in 16 centers, between 2009 and 2011. Fifty-five type 1 GD patients were included, under the care of an internist or an haematologist. They were originally hospitalized in 8 different specialized units. Diagnosis was established by bone-marrow aspiration in 22 patients (40%), by enzymatic assay of glucocerebrosidase activity in 15 patients (27%), and by bone-marrow biopsy in 9 patients (16%). The use of enzymatic assay became more frequent after 1990. The delay between first hospitalization due to GD symptoms and definitive diagnosis was less than one year for 38 patients. Patients with suspected GD were mainly referred to an internist physician. GD seems to be better recognized and quickly diagnosed since 1990 in spite of the multiplicity of journeys. The role of the internist seems important.

Identifiants

pubmed: 31500934
pii: S0248-8663(19)30612-5
doi: 10.1016/j.revmed.2019.07.011
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

fre

Sous-ensembles de citation

IM

Pagination

778-784

Informations de copyright

Copyright © 2019 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

S Deriaz (S)

CHRU, université de Tours, service de médecine interne, Tours, France.

C Serratrice (C)

Service de médecine interne, hôpital Saint-Joseph, Marseille, France; Département de médecine interne et réhabilitation, hôpital universitaire de Genève, Suisse.

O Lidove (O)

Service de médecine interne, hôpital de la Croix Saint-Simon, Paris, France.

E Noël (E)

Service de médecine interne, CHRU de Strasbourg, Strasbourg, France.

A Masseau (A)

Service de médecine interne, CHRU de Nantes, Nantes, France.

B Lorcerie (B)

Service de médecine interne, CHRU de Dijon, Dijon, France.

R Jaussaud (R)

Service de médecine interne, CHRU de Reims, Reims, France.

I Marie (I)

Service de médecine interne, CHRU de Rouen, Rouen, France.

C Lavigne (C)

Service de médecine interne, CHRU d'Angers, Angers, France.

J Cabane (J)

Service de médecine interne, hôpital Saint-Antoine, Paris, France.

P Kaminsky (P)

Service de médecine interne, CHRU de Nancy, Nancy, France.

P Chérin (P)

Service de médecine interne, hôpital de la Pitié-Salpétrière, Paris, France.

F Maillot (F)

CHRU, université de Tours, service de médecine interne, Tours, France. Electronic address: francois.maillot@univ-tours.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH